Kenvue stock rose 2.3%, closing at 21.82. Earlier on today's stock market, shares jumped nearly 6%. Shares hit a 2025 peak at 25.17 intraday on May 8.

Throughout the last three months, 6 analysts have evaluated Kenvue (NYSE:KVUE), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their ...

Kenvue: Tylenol Can't Ease The Pain, Pricey Stock, Dividend In Vain Jul. 22, 2025 5:30 AM ET Kenvue Inc. (KVUE) Stock JNJ, KVUE Alan Galecki 233 Follower s ...

Shares of Kenvue Inc. KVUE rallied 2.44% to $22.67 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

Kenvue updated its FY25 outlook to reflect higher tariff costs and currency impacts, while its Q1 sales beat consensus. The market’s back, and these 3 income stocks are thriving.

Kenvue carries fewer risks and its products are iconic and essential brands; it offers steady dividends, and long-term growth. Read why KVUE is suitable for dividend investors.

Shares of Kenvue Inc. KVUE shed 2.08% to $23.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining ...

Kenvue will report its full quarterly results on Aug. 7 and said that it will revise its full-year outlook on that date. Shares rose more than 4% before the market open.

NEW YORK, June 12 (Reuters) - Kenvue (KVUE.N) is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, and a low estimate of $22.00. This current average has decreased by 0. ...